Physician profile
Lauren Libfraind
NPI 1588197818
$2,720.23
in general payments reported to CMS, 2019-2025
17 companies · $234 in 2025
The $234 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2021: $65.10 · 2022: $424 · 2023: $1,151 · 2024: $721 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,039 · Entertainment: $42.25 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,038.65 |
| Entertainment | $42.25 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,406.22 | 2022-2025 | Wavelight Refractive Suite, Acrysof Iq Panoptix Uv Iol, Clareon |
| Abbvie INC. | $251.83 | 2023-2025 | |
| Allergan, INC. | $205.87 | 2019-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $158.54 | 2024 | Tecnis Simplicity, Tecnis Iol |
| Rxsight INC | $139.98 | 2023-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Rayner Intraocular Lenses Limited | $105.92 | 2022-2025 | Rayone Emv, Rayone Aspheric, Rayone Spheric |
| Bausch & Lomb Americas INC. | $94.80 | 2023-2024 | Xiidra, Miebo, Envista Mx60 Iol |
| Biotissue Holdings INC. | $72.63 | 2021-2023 | |
| Oyster Point Pharma, INC. | $66.05 | 2022-2023 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $54.13 | 2023-2025 | Cequa |
| Optos, INC. | $42.25 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Amgen INC. | $39.35 | 2025 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $28.56 | 2025 | Xdemvy |
| Omeros Corporation | $19.17 | 2021 | |
| Dompe US, INC. | $18.97 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oasis Medical, INC. | $15.96 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Libfraind listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.